EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IgG Subclass ( IgG1 ‐4) and IgA Autoantibody Profiles Against Muscle‐Specific Kinase in a Greek Cohort

Sofia-Natsοuko Gkotzamani iD, Maria Pechlivanidou iD, Francisca Faber iD, Cansu Elmas iD, Vasiliki Zouvelou iD, Elisabeth Chroni iD, Dimitrios Tzanetakos iD, Maria Kourouvani, Marlene Wolfsgruber iD, Ioannis Zaganas iD, Dimitra Kolovou, Michael Rentzos und 11 weitere

Muscle & Nerve · 2026

DOI: 10.1002/mus.70284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Sofia-Natsοuko Gkotzamani und 22 weiteren Autor:innen. Beteiligte Einrichtung: Tzartos NeuroDiagnostics, Athens, Greece. Hauptthemen laut MEDLINE: Autoantibodies, Immunoglobulin G, Immunoglobulin A, Myasthenia Gravis. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union Horizon research and innovation MSCA Doctoral Networks 2022 program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Muscle‐specific kinase myasthenia gravis (MuSK‐MG) is an autoimmune neuromuscular disorder predominantly mediated by IgG4 autoantibodies disrupting MuSK signaling. The contribution of other isotypes remains incompletely defined. We characterized the serological profile of a Greek cohort of MuSK‐MG patients.

Methods

Baseline ( n = 140) and longitudinal (available n = 99) samples from 140 patients, positive for anti‐MuSK by radioimmunoprecipitation (RIPA) were analyzed using a live cell‐based assay (L‐CBA) to detect total IgG, IgG1–4 subclasses, IgM, and IgA. Also, disease and healthy controls ( n = 102) were included. Selected samples were additionally analyzed by flow cytometry. Clinical data were available for specific patients.

Results

Our analysis revealed 15 distinct immunoglobulin combinations and provided insights into the presence of IgA isotype. IgG4 was the most common subclass in 120/140 of patients, followed by IgG1 in 79/140, IgG3 in 59/140, and IgG2 in 42/140 patients, while IgM positivity was detected in selected patients. Anti‐MuSK IgA(1) immunoreactivity was detected in 54/140 patients, frequently co‐occurring with IgG, and in four patients at baseline with only‐IgA positivity. IgA was detected both near disease onset and at later stages, and persisted over time in rituximab‐treated patients. Controls tested largely negative for IgA, although low‐intensity signals were observed in six samples and were considered non‐specific. L‐CBA detected anti‐MuSK IgA more frequently than flow cytometry.

Discussion

Our findings expand the serology of MuSK‐MG beyond IgG subclasses, identifying IgA as an additional component of the anti‐MuSK response. These results enhance further investigation into the clinical significance, pathogenic potential, and treatment‐associated fluctuations of anti‐MuSK IgA antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesImmunoglobulin GImmunoglobulin AMyasthenia GravisReceptor Protein-Tyrosine KinasesReceptors, CholinergicHumansMaleFemaleGreeceCohort StudiesAdultMiddle AgedAgedYoung AdultAdolescent

Stichwörter der Autor:innen

CBAIgA isotypeIgG subclassesMuSK‐MGautoantibodies

Substanzen

AutoantibodiesImmunoglobulin GImmunoglobulin AMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, Cholinergic

Autor:innen und Institutionen

  • Tzartos NeuroDiagnostics, Athens, Greece.
  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
  • Department of Immunology, Hellenic Pasteur Institute, Athens, Greece.
  • Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • First Department of Neurology "Eginition" Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Neurology, School of Medicine, University of Patras, Rio-Patra, Greece.

ORCID-Profile: Sofia-Natsοuko Gkotzamani, Maria Pechlivanidou, Francisca Faber, Cansu Elmas, Vasiliki Zouvelou, Elisabeth Chroni, Dimitrios Tzanetakos, Marlene Wolfsgruber, Ioannis Zaganas, Ariadne Daponte, Spyridon Konitsiotis, Konstandinos Lazaridis, Georgios Tsivgoulis, Inga Koneczny, John S Tzartos

Förderung

  • European Union Horizon research and innovation MSCA Doctoral Networks 2022 program

Zitieren

APA

Gkotzamani, S. N., Pechlivanidou, M., Faber, F., Elmas, C., Zouvelou, V., Chroni, E., Tzanetakos, D., Kourouvani, M., Wolfsgruber, M., Zaganas, I., Kolovou, D., Rentzos, M., Daponte, A., Chondrogiorgi, M., Konitsiotis, S., Nicolaou, G., Salakou, S., Giannopoulos, S., Lazaridis, K., …, & Tzartos, J. S. (2026). IgG Subclass ( IgG1 ‐4) and IgA Autoantibody Profiles Against Muscle‐Specific Kinase in a Greek Cohort. Muscle & Nerve. https://doi.org/10.1002/mus.70284

Vancouver

Gkotzamani SN, Pechlivanidou M, Faber F, Elmas C, Zouvelou V, Chroni E, et al. IgG Subclass ( IgG1 ‐4) and IgA Autoantibody Profiles Against Muscle‐Specific Kinase in a Greek Cohort. Muscle & Nerve. 2026. doi:10.1002/mus.70284

BibTeX
@article{Gkotzamani2026,
  author = {Gkotzamani, Sofia-Natsοuko and Pechlivanidou, Maria and Faber, Francisca and Elmas, Cansu and Zouvelou, Vasiliki and Chroni, Elisabeth and Tzanetakos, Dimitrios and Kourouvani, Maria and Wolfsgruber, Marlene and Zaganas, Ioannis and Kolovou, Dimitra and Rentzos, Michael and Daponte, Ariadne and Chondrogiorgi, Maria and Konitsiotis, Spyridon and Nicolaou, Georgios and Salakou, Stavroula and Giannopoulos, Sotirios and Lazaridis, Konstandinos and Tsivgoulis, Georgios and Tzartos, Socrates and Koneczny, Inga and Tzartos, John S},
  title = {IgG Subclass ( IgG1 ‐4) and IgA Autoantibody Profiles Against Muscle‐Specific Kinase in a Greek Cohort},
  journal = {Muscle & Nerve},
  year = {2026},
  doi = {10.1002/mus.70284}
}
Kostenlos starten →